Toggle light / dark theme

Senolytics to remove senescent cells will deliver the first “repair” based approach to treat the aging process. This is the arrival of true rejuvenation biotechnology in the SENS model of damage repair.


Senescent cell removal with companies such as Unity, entering human clinical trials in the next 18 months will deliver the first true damage repair rejuevenation biotechnology. This will be the first “repair” approach to the aging process and one the SENS Research Foundation has been advocating for over a decade.

#aging #crowdfundthecure

Read more

As I stated earlier, another example where we will see a convergence of tech and bio especially as we emerge QC forward and synbio technology such as gene/ cell circuitry. My guess when we mature these fields along with minerals like diamonds/ gem crystalized formation and their use in QC tech, we will began to wonder why we didn’t figure this out sooner.


When Edward Boyden was helping develop a tool to turn neurons on and off with light at Stanford a decade ago, he had a strong feeling it would spread far and wide. Even so, he’s been surprised by how quickly its fame has come.

“What I hadn’t quite anticipated was how fast it would take off,” said Boyden, who now leads the MIT Media Lab’s synthetic neurobiology research group. “It was almost as if the field was ready for the technology.”

It certainly was. On Sunday, Boyden and Stanford neuroscientist Dr. Karl Deisseroth, whose lab Boyden worked in, each received $3 million Breakthrough Prizes for their work on optogenetics.

Read more

Philadelphia, PA, USA / Moscow, Russia — Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, announced the commercial approval of naturally derived Bioquantine food ingredients in the Eurasian Customs Union (formerly known as the Customs Union of Belarus, Kazakhstan, and Russia). Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, collaborated with Bioquark Inc. on the regulatory approvals.

green-cell

“We are very excited about this successful regulatory approval,” said Ira S. Pastor, CEO, Bioquark Inc. “The commercialization of Bioquantine food ingredients, including functional foods, drinks, and dietary supplements, represents another important step in our continued evolution as a company focused on a broad range of products and services in the regenerative healthcare space.”

Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.

gene-sequencing

The integration of a complex set of newer research disciplines, including interkingdom signaling, semiochemical communication, and evolutionary biology, as well as significant recent activity in the areas of the microbiome and virome, are highlighting a myriad of new ways that non-human bio-products can affect the human genome for positive transitions in health and wellness dynamics.

“Bioquark has spent several years studying the natural ability of many species to turn back biological time in order to maintain health, fitness, and survival,” said Dr. Sergei Paylian, Founder, CSO, and President, Bioquark Inc. “This Eurasian initiative is one more step in the path in allowing humans to recapture these capabilities to effectively counter our unfortunate progression into aging, disease and degeneration.”

bqaproduction

About Bioquark, Inc.

Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.

Link to Press — http://www.prweb.com/releases/2017/01/prweb13955162.htm

Since their development in 1960, lasers have become an indispensable tool supporting our modern society, finding use in fields such as medicine, information, and industry. Thanks to their compact size and energy efficiency, semiconductor lasers are now one of the most important classes of laser, making possible a diverse range of applications. However, the threshold current of a typical semiconductor laser—the minimum electrical current required to induce lasing—increases with temperature. This is one of a number of disadvantages that can be overcome by using quantum dot lasers. Professor Yasuhiko Arakawa of the Institute of Industrial Science at the University of Tokyo has been researching quantum dot lasers for about 35 years, from their conception to commercialization.

An electron trapped in a microscopic box

Sunlight is composed of light of various colors. The property that determines the color of light is its wavelength, or in other words, the distance between two successive wave peaks or troughs. The location of the peaks and troughs in the waveform is known as its phase. As a laser emits light waves in a uniform phase at the same wavelength, the light can be transmitted as a beam over long distances at high intensity.

Read more

In “Passengers,” a 2016 science-fiction thriller film two space travelers wake up 90 years too soon from an induced hibernation on board a spaceship bound for a new planet. From “Aliens” to “Interstellar,” Hollywood has long used suspended animation to overcome the difficulties of deep space travel, but the once-fanciful sci-fi staple is becoming scientific fact. The theory is that a hibernating crew could stay alive over vast cosmic distances, requiring little food, hydration or living space, potentially slashing the costs of interstellar missions and eradicating the boredom of space travel.

Read more

Scientists are able to use brain tests on three-year-olds to determine which children are more likely to grow up to become criminals. It sounds like Minority Report come to life: An uncomfortable idea presenting myriad ethical concerns. But, though unnerving, the research is nuanced and could potentially be put to good use.

In the study, published in Nature Human Behavior this week, researchers led by neuroscientists at Duke University showed that those with the lowest 20% brain health results aged three went on to commit more than 80% of crimes as adults. The research used data from a New Zealand longitudinal study of more than 1,000 people from birth in the early 1970s until they reached 38 years old. This distribution, of 20% of a population accounting for 80% of an effect, is strong but not unusual. In fact, it follows the “Pareto principle.” The authors write in their paper:

In Pareto’s day, the problem definition was that 20% of families owned 80% of land in Italy. The so-called Pareto principle is alive and useful today: for example, in software engineering, 20% of the code is said to contain 80% of the errors.

Read more

Robots have been a major focus in the technology world for decades and decades, but they and basic science, and for that matter everyday life, have largely been non-overlapping magisteria. That’s changed over the last few years, as robotics and every other field have come to inform and improve each other, and robots have begun to infiltrate and affect our lives in countless ways. So the only surprise in the news that the prestigious journal group Science has established a discrete Robotics imprint is that they didn’t do it earlier.

Editor Guang-Zhong Yang and president of the National Academy of Sciences Marcia McNutt introduce the journal:

In a mere 50 years, robots have gone from being a topic of science fiction to becoming an integral part of modern society. They now are ubiquitous on factory floors, build complex deep-sea installations, explore icy worlds beyond the reach of humans, and assist in precision surgeries… With this growth, the research community that is engaged in robotics has expanded globally. To help meet the need to communicate discoveries across all domains of robotics research, we are proud to announce that Science Robotics is open for submissions.

Read more

It is not often that a scientist walks the red carpet at a Silicon Valley party and has Morgan Freeman award them millions of dollars while Alicia Keys performs on stage and other A-listers rub shoulders with NASA astronauts.

But the guest list for the Breakthrough prize ceremony is intended to make it an occasion. At the fifth such event in California last night, a handful of the world’s top researchers left their labs behind for the limelight. Honoured for their work on black holes and string theory, DNA repair and rare diseases, and unfathomable modifications to Schrödinger’s equation, they went home to newly recharged bank accounts.

Founded by Yuri Milner, the billionaire tech investor, with Facebook’s Mark Zuckerberg and Google’s Sergey Brin, the Breakthrough prizes aim to right a perceived wrong: that scientists and engineers are not appreciated by society. With lucrative prizes and a lavish party dubbed “the Oscars of science”, Milner and his companions want to elevate scientists to rock star status.

Read more